| # | Drug | Count |
|---|---|---|
| 0 | CYCLOPHOSPHAMIDE | 713 |
| 1 | CYCLOPHOSPHAMIDE FOR INJECTION | 713 |
| 2 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 713 |
| 3 | DEFIBROTIDE SODIUM | 565 |
| 4 | BUSULFAN | 533 |
| 5 | FLUDARABINE PHOSPHATE | 426 |
| 6 | METHOTREXATE SODIUM | 422 |
| 7 | METHOTREXATE | 383 |
| 8 | CYTARABINE | 321 |
| 9 | ETOPOSIDE | 287 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DEFIBROTIDE SODIUM | 565 | 0.1576 |
| 1 | OMIDUBICEL-ONLV | 2 | 0.0909 |
| 2 | INOTUZUMAB OZOGAMICIN | 132 | 0.0441 |
| 3 | DACTINOMYCIN | 74 | 0.0335 |
| 4 | BUSULFAN | 533 | 0.0335 |
| 5 | GEMTUZUMAB OZOGAMICIN | 109 | 0.0297 |
| 6 | TRIPLE ANTIBIOTIC OINTMENT | 1 | 0.0250 |
| 7 | SODIUM CITRATE AND CITRIC ACID | 1 | 0.0208 |
| 8 | THIOGUANINE | 42 | 0.0198 |
| 9 | WHITE PETROLEUM | 1 | 0.0192 |
| # | Drug class | Count |
|---|---|---|
| 0 | Alkylating Drug [EPC] | 1084 |
| 1 | Corticosteroid [EPC] | 476 |
| 2 | Nucleoside Metabolic Inhibitor [EPC] | 398 |
| 3 | Folate Analog Metabolic Inhibitor [EPC] | 383 |
| 4 | Topoisomerase Inhibitor [EPC] | 294 |
| 5 | Calcineurin Inhibitor Immunosuppressant [EPC] | 262 |
| 6 | Bile Acid [EPC] | 191 |
| 7 | Platinum-based Drug [EPC] | 181 |
| 8 | Azole Antifungal [EPC] | 170 |
| 9 | CD22-directed Immunoconjugate [EPC] | 132 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD22-directed Immunoconjugate [EPC] | 132 | 0.0441 |
| 1 | Actinomycin [EPC] | 74 | 0.0335 |
| 2 | CD33-directed Immunoconjugate [EPC] | 109 | 0.0297 |
| 3 | Bile Acid [EPC] | 191 | 0.0083 |
| 4 | CD52-directed Cytolytic Antibody [EPC] | 105 | 0.0054 |
| 5 | Lymphocyte Growth Factor [EPC] | 6 | 0.0048 |
| 6 | Asparagine-specific Enzyme [EPC] | 60 | 0.0045 |
| 7 | Alkylating Drug [EPC] | 1084 | 0.0044 |
| 8 | Hematopoietic Stem Cell Mobilizer [EPC] | 6 | 0.0040 |
| 9 | Cytomegalovirus DNA Terminase Complex Inhibitor [EPC] | 13 | 0.0040 |